|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided from operating activities: | |||||
| Deferred income tax expense (benefit) | |||||
| Depletion, depreciation and amortization | |||||
| Abandonment and impairment of unproved properties | |||||
| Derivative fair value income | |||||
| Cash settlements on derivative financial instruments | |||||
| Divestiture contract obligation, including accretion | |||||
| Allowance for bad debt | |||||
| Amortization of debt issuance costs and other | |||||
| Deferred and stock-based compensation | |||||
| Gain on the sale of assets | |||||
| Gain on early extinguishment of debt | |||||
| Changes in working capital: | |||||
| Accounts receivable | |||||
| Other current assets | |||||
| Accounts payable | |||||
| Accrued liabilities and other | |||||
| Net cash provided from operating activities | |||||
| Investing activities: | |||||
| Additions to natural gas, NGLs and oil properties | |||||
| Additions to field service assets and other | |||||
| Acreage purchases | |||||
| Proceeds from disposal of assets | |||||
| Purchases of marketable securities held by the deferred compensation plan | |||||
| Proceeds from the sales of marketable securities held by the deferred compensation plan | |||||
| Net cash used in investing activities | |||||
| Financing activities: | |||||
| Borrowings on credit facility | |||||
| Repayments on credit facility | |||||
| Issuance of senior notes | |||||
| Repayment of senior notes | |||||
| Dividends paid | |||||
| Treasury stock purchases | |||||
| Debt issuance costs | |||||
| Taxes paid for shares withheld | |||||
| Change in cash overdrafts | |||||
| Proceeds from the sales of common stock held by the deferred compensation plan | |||||
| Net cash used in financing activities | |||||
| (Decrease) increase in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
Loading...